Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer

Authors: Mingxing Lei, Yaosheng Liu, Chuanghao Tang, Shaoxing Yang, Shubin Liu, Shiguo Zhou

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

The aim of this study was to develop a scoring system for prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC).

Methods

We retrospectively analyzed nine preoperative characteristics for survival in a series of 64 patients with NSCLC who were operated with posterior decompression and spine stabilization for MSCC. Characteristics significantly associated with survival on multivariate analysis were included in the scoring system. The scoring point for each significant characteristic was derived from the hazard ratios on Cox proportional hazards model. The total score for each patient was obtained by adding the scoring points of all significant characteristics.

Results

Eastern Cooperative Oncology Group (ECOG) performance status, number of involved vertebrae, visceral metastases, and time developing motor deficits had significant impact on survival on multivariate analysis and were included in the scoring system. According to the prognostic scores, which ranged from 4 to 10 points, three prognostic groups were designed: 4–5 points (n = 22), 6–7 points (n = 23), and 8–10 points (n = 19). The corresponding 6-month survival rates were 95, 47 and 11 %, respectively (P < 0.0001). In addition, the functional outcome was worse in the group of patients with 8–10 points compared with other two prognostic groups.

Conclusions

The new scoring system will enable physicians to identify patient with MSCC from NSCLC who may be a candidate for decompression and spine stabilization, more radical surgery, or supportive care alone. Patients with scores of 4–5, who have the most favorable survival prognosis and functional outcome, can be treated with more radical surgery in order to realize better local control of disease and prevent the occurrence of local disease. Patients with scores of 6–7 points should be surgical candidates, because survival prognosis and functional outcome are acceptable after surgery, while patients with scores of 8–10 points, who have the shortest survival time and poorest functional outcome after surgery, appear to be best treated with radiotherapy or best supportive care.
Literature
2.
go back to reference Hirabayashi H, Ebara S, Kinoshita T, Yuzawa Y, Nakamura I, Takahashi J, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer. 2003;97:476–84.CrossRefPubMed Hirabayashi H, Ebara S, Kinoshita T, Yuzawa Y, Nakamura I, Takahashi J, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer. 2003;97:476–84.CrossRefPubMed
3.
go back to reference Silva GT, Bergmann A, Thuler LC. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer. Spine J. 2015;15:1263–9.CrossRefPubMed Silva GT, Bergmann A, Thuler LC. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer. Spine J. 2015;15:1263–9.CrossRefPubMed
4.
go back to reference Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K. The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine. 2005;30:2222–6.CrossRefPubMed Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K. The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine. 2005;30:2222–6.CrossRefPubMed
5.
go back to reference Wai EK, Finkelstein JA, Tangente RP, Holden L, Chow E, Ford M, et al. Quality of life in surgical treatment of metastatic spine disease. Spine. 2003;28:508–12.PubMed Wai EK, Finkelstein JA, Tangente RP, Holden L, Chow E, Ford M, et al. Quality of life in surgical treatment of metastatic spine disease. Spine. 2003;28:508–12.PubMed
6.
go back to reference Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643–8.CrossRefPubMed Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366:643–8.CrossRefPubMed
7.
go back to reference Chen YJ, Chang GC, Chen HT, Yang TY, Kuo BIT, Hsu HC, et al. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine. 2007;32:E413–8.CrossRefPubMed Chen YJ, Chang GC, Chen HT, Yang TY, Kuo BIT, Hsu HC, et al. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine. 2007;32:E413–8.CrossRefPubMed
9.
go back to reference Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990;15:1110–3.CrossRefPubMed Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990;15:1110–3.CrossRefPubMed
10.
go back to reference Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30:2186–91.CrossRefPubMed Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30:2186–91.CrossRefPubMed
11.
go back to reference Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26:298–306.CrossRefPubMed Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26:298–306.CrossRefPubMed
12.
go back to reference Van Der Linden YM, Dijkstra SPDS, Vonk EJA, Marijnen CAM, Leer JWH. Prediction of survival in patients with metastases in the spinal column. Results based on a randomized trial of radiotherapy. Cancer. 2005;103:320–8.CrossRefPubMed Van Der Linden YM, Dijkstra SPDS, Vonk EJA, Marijnen CAM, Leer JWH. Prediction of survival in patients with metastases in the spinal column. Results based on a randomized trial of radiotherapy. Cancer. 2005;103:320–8.CrossRefPubMed
13.
go back to reference Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer. 1995;76:1453–9.CrossRefPubMed Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer. 1995;76:1453–9.CrossRefPubMed
14.
go back to reference Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143–6.CrossRefPubMed Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66:143–6.CrossRefPubMed
15.
go back to reference Bartels RH, Feuth T, Van Der Maazen R, Verbeek AL, Kappelle AC, Grotenhuis JA, et al. Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer. 2007;110:2042–9.CrossRefPubMed Bartels RH, Feuth T, Van Der Maazen R, Verbeek AL, Kappelle AC, Grotenhuis JA, et al. Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer. 2007;110:2042–9.CrossRefPubMed
16.
go back to reference Hessler C, Vettorazzi E, Madert J, Bokemeyer C, Panse J. Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine. 2011;36:983–9.CrossRefPubMed Hessler C, Vettorazzi E, Madert J, Bokemeyer C, Panse J. Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine. 2011;36:983–9.CrossRefPubMed
17.
go back to reference Morgen SS, Lund-Andersen C, Larsen CF, Engelholm SA, Dahl B. Prognosis in patients with symptomatic metastatic spinal cord compression: survival in different cancer diagnosis in a cohort of 2321 patients. Spine. 2013;38:1362–7.CrossRefPubMed Morgen SS, Lund-Andersen C, Larsen CF, Engelholm SA, Dahl B. Prognosis in patients with symptomatic metastatic spinal cord compression: survival in different cancer diagnosis in a cohort of 2321 patients. Spine. 2013;38:1362–7.CrossRefPubMed
18.
go back to reference Carr LL, Finigan JH, Kern JA. Evaluation and treatment of patients with non-small cell lung cancer. Med Clin North Am. 2011;95:1041–54.CrossRefPubMed Carr LL, Finigan JH, Kern JA. Evaluation and treatment of patients with non-small cell lung cancer. Med Clin North Am. 2011;95:1041–54.CrossRefPubMed
19.
go back to reference Cagle PT, Chirieac LR. Advances in treatment of lung cancer with targeted therapy. Arch Path Lab Med. 2012;136:504–9.CrossRefPubMed Cagle PT, Chirieac LR. Advances in treatment of lung cancer with targeted therapy. Arch Path Lab Med. 2012;136:504–9.CrossRefPubMed
20.
go back to reference Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia. 1969;7:179–92.CrossRefPubMed Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia. 1969;7:179–92.CrossRefPubMed
22.
go back to reference Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL. Metastatic disease of the spine: evaluation and treatment. Clin Orthop Relat Res. 2003;415:S165–75.CrossRefPubMed Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL. Metastatic disease of the spine: evaluation and treatment. Clin Orthop Relat Res. 2003;415:S165–75.CrossRefPubMed
23.
go back to reference Crnalic S, Löfvenberg R, Bergh A, Widmark A, Hildingsson C. Predicting survival for surgery of metastatic spinal cord compression in prostate cancer: a new score. Spine. 2012;37:2168–76.CrossRefPubMed Crnalic S, Löfvenberg R, Bergh A, Widmark A, Hildingsson C. Predicting survival for surgery of metastatic spinal cord compression in prostate cancer: a new score. Spine. 2012;37:2168–76.CrossRefPubMed
24.
go back to reference Yamashita T, Siemionow KB, Mroz TE, Podichetty V, Lieberman IH. A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine. 2011;36:910–7.CrossRefPubMed Yamashita T, Siemionow KB, Mroz TE, Podichetty V, Lieberman IH. A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine. 2011;36:910–7.CrossRefPubMed
25.
go back to reference Quraishi NA, Manoharan SR, Arealis G, Khurana A, Elsayed S, Edwards KL, et al. Accuracy of the revised Tokuhashi score in predicting survival in patients with Metastatic Spinal Cord Compression (MSCC). Eur Spine J. 2013;22:S21–6.CrossRefPubMed Quraishi NA, Manoharan SR, Arealis G, Khurana A, Elsayed S, Edwards KL, et al. Accuracy of the revised Tokuhashi score in predicting survival in patients with Metastatic Spinal Cord Compression (MSCC). Eur Spine J. 2013;22:S21–6.CrossRefPubMed
26.
go back to reference Rades D, Douglas S, Veninga T, Schild SE. A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer. 2012;12:302.PubMedCentralCrossRefPubMed Rades D, Douglas S, Veninga T, Schild SE. A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer. 2012;12:302.PubMedCentralCrossRefPubMed
27.
go back to reference Moon KY, Chung CK, Jahng TA, Kim HJ, Kim CH. Postoperative survival and ambulatory outcome in metastatic spinal tumors : prognostic factor analysis.J Korean Neurosurg Soc. 2011;50:216–23.PubMedCentralCrossRefPubMed Moon KY, Chung CK, Jahng TA, Kim HJ, Kim CH. Postoperative survival and ambulatory outcome in metastatic spinal tumors : prognostic factor analysis.J Korean Neurosurg Soc. 2011;50:216–23.PubMedCentralCrossRefPubMed
28.
go back to reference Bach F, Agerlin N, Sorensen JB, Rasmussen TB, Dombernowsky P, Sorensen PS, et al. Metastatic spinal cord compression secondary to lung cancer. J Clin Oncol. 1992;10:1781–7.PubMed Bach F, Agerlin N, Sorensen JB, Rasmussen TB, Dombernowsky P, Sorensen PS, et al. Metastatic spinal cord compression secondary to lung cancer. J Clin Oncol. 1992;10:1781–7.PubMed
Metadata
Title
Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer
Authors
Mingxing Lei
Yaosheng Liu
Chuanghao Tang
Shaoxing Yang
Shubin Liu
Shiguo Zhou
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1852-2

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine